Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
The SARS-CoV-2 vaccine produced by the US biotechnology company Novavax is 95.6% effective against the original variant of SARS-CoV-2 but also provides protection against the newer variants B.1.1.7…
